A detailed history of D. E. Shaw & Co., Inc. transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 120,648 shares of RDY stock, worth $1.85 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
120,648
Holding current value
$1.85 Million
% of portfolio
0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$75.41 - $84.21 $9.1 Million - $10.2 Million
120,648 New
120,648 $9.59 Million
Q4 2023

Feb 14, 2024

BUY
$64.27 - $69.9 $652,854 - $710,044
10,158 New
10,158 $706,000
Q2 2023

Aug 14, 2023

SELL
$53.34 - $63.11 $5.89 Million - $6.97 Million
-110,385 Reduced 79.87%
27,817 $1.76 Million
Q1 2023

May 15, 2023

BUY
$51.63 - $56.93 $3.38 Million - $3.73 Million
65,444 Added 89.95%
138,202 $7.87 Million
Q4 2022

Feb 14, 2023

SELL
$51.15 - $57.45 $839,320 - $942,697
-16,409 Reduced 18.4%
72,758 $3.77 Million
Q3 2022

Nov 14, 2022

SELL
$49.9 - $57.32 $7.78 Million - $8.93 Million
-155,856 Reduced 63.61%
89,167 $4.67 Million
Q2 2022

Aug 15, 2022

SELL
$49.62 - $58.13 $2.87 Million - $3.36 Million
-57,746 Reduced 19.07%
245,023 $13.6 Million
Q1 2022

May 16, 2022

BUY
$48.27 - $65.25 $7.46 Million - $10.1 Million
154,502 Added 104.21%
302,769 $16.9 Million
Q4 2021

Feb 14, 2022

BUY
$59.5 - $67.25 $3.55 Million - $4.02 Million
59,722 Added 67.45%
148,267 $9.7 Million
Q3 2021

Nov 15, 2021

SELL
$60.19 - $75.29 $4.01 Million - $5.02 Million
-66,631 Reduced 42.94%
88,545 $5.77 Million
Q2 2021

Aug 16, 2021

BUY
$62.12 - $74.2 $1.69 Million - $2.02 Million
27,227 Added 21.28%
155,176 $11.4 Million
Q1 2021

May 17, 2021

SELL
$57.98 - $73.08 $1.02 Million - $1.29 Million
-17,634 Reduced 12.11%
127,949 $7.86 Million
Q4 2020

Feb 16, 2021

BUY
$62.61 - $71.29 $224,269 - $255,360
3,582 Added 2.52%
145,583 $10.4 Million
Q3 2020

Nov 16, 2020

SELL
$51.39 - $72.41 $756,255 - $1.07 Million
-14,716 Reduced 9.39%
142,001 $9.88 Million
Q2 2020

Aug 14, 2020

SELL
$39.55 - $54.65 $4.18 Million - $5.78 Million
-105,752 Reduced 40.29%
156,717 $8.31 Million
Q1 2020

May 15, 2020

SELL
$34.75 - $45.85 $744,414 - $982,198
-21,422 Reduced 7.55%
262,469 $10.6 Million
Q4 2019

Feb 14, 2020

BUY
$36.66 - $41.78 $2.06 Million - $2.35 Million
56,157 Added 24.66%
283,891 $11.5 Million
Q3 2019

Nov 14, 2019

BUY
$34.82 - $39.26 $1.33 Million - $1.5 Million
38,295 Added 20.21%
227,734 $8.63 Million
Q2 2019

Aug 14, 2019

SELL
$36.05 - $42.76 $3.91 Million - $4.64 Million
-108,419 Reduced 36.4%
189,439 $7.1 Million
Q1 2019

May 15, 2019

SELL
$35.77 - $40.57 $639,317 - $725,107
-17,873 Reduced 5.66%
297,858 $12.1 Million
Q4 2018

Feb 14, 2019

BUY
$31.89 - $38.44 $83,711 - $100,905
2,625 Added 0.84%
315,731 $11.9 Million
Q3 2018

Nov 14, 2018

SELL
$29.25 - $36.73 $6.21 Million - $7.79 Million
-212,217 Reduced 40.4%
313,106 $10.8 Million
Q2 2018

Aug 14, 2018

BUY
$28.49 - $35.06 $13.6 Million - $16.8 Million
477,848 Added 1006.53%
525,323 $16.9 Million
Q1 2018

May 15, 2018

BUY
$31.93 - $39.54 $1.52 Million - $1.88 Million
47,475 New
47,475 $1.55 Million
Q4 2017

Feb 14, 2018

SELL
$34.15 - $37.62 $927,172 - $1.02 Million
-27,150 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$30.11 - $37.72 $817,486 - $1.02 Million
27,150
27,150 $969,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.55B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.